- Historical context30th pct
- Persistence5 periods
- Independent evidence1 group
· Pharmaceutical Preparations
RESEARCH SNAPSHOTANI PHARMACEUTICALS INC's latest supported as-filed period reports revenue of $266.0M, 25.9% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
Unusual transitions and combinations worth inspecting—not forecasts or recommendations.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 113.32% · OPTIONAL
Level · gp.fundamentals.capex_revenue_ratio
Raw value 1.15% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 21.30% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 25.87% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 53.81% · OPTIONAL
Level · gp.fundamentals.operating_margin
Raw value 15.21% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 3 independently calculated changes: Revenue increased 25.9%; Operating margin moved 864 bp higher; Operating income increased 191.2%.
3 evidence-backed componentsStockholders' equity changed +36.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
ANIP · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001674236-26-000022SEC ↗4Aug 27, 2026Period Aug 19, 20260001659625-26-000011SEC ↗4Aug 26, 2026Period Aug 25, 20260001822629-26-000014SEC ↗8-KAug 24, 2026Period Aug 19, 20260001023024-26-000071SEC ↗4Aug 13, 2026Period Aug 13, 20260001938861-26-000023SEC ↗4Aug 11, 2026Period Aug 10, 20260001846478-26-000015SEC ↗10-QAug 7, 2026Period Jun 30, 20260001023024-26-000069SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 31, 2026Filed Sep 1, 2026 | CAREY STEPHEN P.SVP & CFO | Open Market SaleDirect | 2,850 | $73 | $207,480 | Form 4 ↗ |
| Aug 25, 2026Filed Aug 26, 2026 | Lalwani NikhilPRESIDENT & CEO | Open Market SaleDirect | 5,400 | $74 | $401,220 | Form 4 ↗ |
| Aug 19, 2026Filed Aug 27, 2026 | Gosebruch Henry ODirector | Grant Or AwardDirect | 6,662 | $0 | $0 | Form 4 ↗ |
| Aug 13, 2026Filed Aug 13, 2026 | Cook MeredithSR. VP, GENERAL COUNSEL & SEC. | Open Market SaleDirect | 500 | $75 | $37,740 | Form 4 ↗ |
| Aug 10, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 5.54% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 4.29% · OPTIONAL
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Working capital changed +48.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed -25.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed +191.2% from the comparable as-filed period.
Operating cash flow changed -25.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed +864 basis points from the comparable as-filed period.
Revenue changed +25.9% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001023024-26-000068| Gutwerg OriSVP, GENERICS |
| Open Market SaleDirect |
| 3,162 |
| $77 |
| $243,474 |
| Form 4 ↗ |
| Jul 29, 2026Filed Jul 30, 2026 | CAREY STEPHEN P.SVP & CFO | Open Market SaleDirect | 2,850 | $81 | $231,876 | Form 4 ↗ |
| Jul 18, 2026Filed Jul 21, 2026 | Cook MeredithSR. VP, GENERAL COUNSEL & SEC. | Tax WithholdingDirect | 2,466 | $79 | $195,307 | Form 4 ↗ |
| Jul 13, 2026Filed Jul 14, 2026 | Cook MeredithSR. VP, GENERAL COUNSEL & SEC. | Open Market SaleDirect | 500 | $82 | $40,920 | Form 4 ↗ |
| Jul 2, 2026Filed Jul 6, 2026 | CAREY STEPHEN P.SVP & CFO | Option ExerciseDirect | 3,313 | $50 | $164,027 | Form 4 ↗ |
| Jul 2, 2026Filed Jul 6, 2026 | CAREY STEPHEN P.SVP & CFO | Open Market SaleDirect | 3,313 | $86 | $284,918 | Form 4 ↗ |
| Jul 2, 2026Filed Jul 6, 2026 | CAREY STEPHEN P.SVP & CFO | Option ExerciseDirect | 3,313 | $50 | $164,027 | Form 4 ↗ |
| Jun 29, 2026Filed Jun 30, 2026 | CAREY STEPHEN P.SVP & CFO | Open Market SaleDirect | 2,850 | $84 | $239,742 | Form 4 ↗ |
| Jun 12, 2026Filed Jun 15, 2026 | Cook MeredithSR. VP, GENERAL COUNSEL & SEC. | Open Market SaleDirect | 500 | $82 | $41,015 | Form 4 ↗ |
| May 21, 2026Filed Jun 10, 2026 | Thoma JeanneDirector | Grant Or AwardDirect | 4,357 | $0 | $0 | Form 4 ↗ |
| May 21, 2026Filed Jun 10, 2026 | TANNENBAUM RENEE PDirector | Grant Or AwardDirect | 4,357 | $0 | $0 | Form 4 ↗ |
| May 21, 2026Filed Jun 10, 2026 | Pera Antonio RDirector | Grant Or AwardDirect | 4,357 | $0 | $0 | Form 4 ↗ |
| May 21, 2026Filed Jun 10, 2026 | Leonard Matthew JDirector | Grant Or AwardDirect | 4,357 | $0 | $0 | Form 4 ↗ |